Skip to main content
SpringerLink
Log in

Response to the letter by Dr. Naoya Yamada, and Dr. Koichi Mizuta regarding our manuscript: “Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis”

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yamada N, Sanada Y, Tashiro M, et al. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol. 2017;52:245–52.

    Article  CAS  Google Scholar 

  2. Shirabe K, Bekki Y, Gantumur D, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53:819–26.

    Article  CAS  PubMed  Google Scholar 

  3. Bekki Y, Yoshizumi T, Shimoda S, et al. Hepatic stellate cells secreting WFA+ -M2BP: its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol. 2017;32:1387–93.

    Article  CAS  PubMed  Google Scholar 

  4. Ito Y, Machen NW, Urbaschek R, et al. Biliary obstruction exacerbates the hepatic microvascular inflammatory response to endotoxin. Shock. 2000;14:599–604.

    Article  CAS  PubMed  Google Scholar 

  5. Ito Y, Bethea NW, Baker GL, et al. Hepatic microcirculatory dysfunction during cholestatic liver injury in rats. Microcirculation. 2003;10:421–32.

    Article  PubMed  Google Scholar 

  6. Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2018;13:0098-2997–30070-0.

    Google Scholar 

  7. McConnell M, Iwakiri Y. Biology of portal hypertension. Hepatol Int. 2018;12(Suppl 1):11–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgical Science, Gunma University, Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan

    Ken Shirabe, Dolgormaa Gantumur, Kenichiro Araki & Norihiro Ishii

  2. Department of Surgery and Science, Kyushu University, Graduate School of Medicine, Fukuoka, Fukuoka, Japan

    Yuki Bekki

  3. Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, Japan

    Atsushi Kuno & Hisashi Narimatsu

  4. Department of Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan

    Masashi Mizokami

Authors
  1. Ken Shirabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuki Bekki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dolgormaa Gantumur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenichiro Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norihiro Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Atsushi Kuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hisashi Narimatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masashi Mizokami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken Shirabe.

Additional information

This reply refers to the comment available at: https://doi.org/10.1007/s00535-018-1523-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shirabe, K., Bekki, Y., Gantumur, D. et al. Response to the letter by Dr. Naoya Yamada, and Dr. Koichi Mizuta regarding our manuscript: “Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis”. J Gastroenterol 54, 206–207 (2019). https://doi.org/10.1007/s00535-018-1524-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-018-1524-5

Search

Navigation